Molbio Diagnostics IPO Allotment Status: Check GMP & Listing Date
Molbio Diagnostics IPO was subscribed 70.27 times by the final day. Check the expected allotment date, refund and demat credit dates, GMP, subscription details and how to check your allotment status online.
Molbio Diagnostics IPO Allotment Status: Molbio Diagnostics IPO allotment is expected to be finalised on 13 Aug 2026. Investors can check their allotment status through the registrar, Kfin Technologies Ltd, as well as on BSE and NSE websites.
Molbio Diagnostics IPO Allotment Status: Molbio Diagnostics IPO allotment is expected to be finalised on 13 Aug 2026. The issue was subscribed 70.27 times overall as of 12 Aug, 7.26 pm.
With such demand, allotment chances in Molbio Diagnostics may be lower for many investors. Investors can check their allotment status on BSE, NSE, or Kfin Technologies. Here's a look at the latest allotment details, Molbio Diagnostics subscription figures, GMP, and Molbio Diagnostics listing date.
Molbio Diagnostics IPO Allotment Date and Time
Here are Molbio Diagnostics allotment and listing dates:
-
Allotment Date: 13 Aug 2026
-
Refund Initiation: 14 Aug 2026
-
Demat Credit: 14 Aug 2026
-
Listing Date: 17 Aug 2026
-
Time: 10 AM, 17 Aug 2026
How to Check Molbio Diagnostics IPO Allotment Status
You can check Molbio Diagnostics IPO allotment status through multiple methods, such as:
Method 1: Procedure to Check Molbio Diagnostics IPO Allotment Status Online On NSE
-
First, go to the NSE IPO bid verification link: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
-
Now, select Equity & SME IPO bid details
-
Select MOLBIO
-
Enter your PAN number & application number.
-
And submit to check your allotment status.
Method 2: Procedure to Check Molbio Diagnostics IPO Allotment Status Online On BSE
-
Visit BSE IPO allotment link: https://www.bseindia.com/investors/appli_check
-
Now tick Equity under issue type.
-
Select Molbio Diagnostics from the dropdown.
-
Enter your application number OR PAN number.
-
And fill the captcha and click Search to view allotment.
Method 3: Procedure to check Molbio Diagnostics IPO Allotment Status on Kfin Technologies through PAN Card (Registrar to the issue)
-
Go to Kfin Technologies portal: https://ipostatus.kfintech.com/
-
Choose Molbio Diagnostics IPO from the dropdown list.
-
Now select PAN, Application Number, or DP ID option.
-
Enter the details.
-
And click Submit to see Molbio Diagnostics allotment results.
Molbio Diagnostics IPO DAY 3 Subscription Status
Molbio Diagnostics IPO saw good demand from investors, especially on Day 3. Here's a look at category-wise subscription figures:
|
Category |
Subscription (Times) |
|---|---|
|
QIB (Qualified Institutional Buyers) |
186.39 |
|
NII (Non-Institutional Investors) |
49.80 |
|
Retail Individual Investors |
12.97 |
|
Employee |
13.28 |
|
Total |
70.27 |
Source: NSE, as of 12 Aug 2026, 7.28 PM
-
Molbio Diagnostics IPO saw a good rise in bids on the final day, with strong participation across investor categories. QIB led the demand by subscribing 186.39 times (by 7:25 PM), while retail investors also showed interest with a subscription of 12.97 times (as of 7.25 PM)
-
70.27x oversubscription means allotment may be difficult for many applicants, as demand was higher than the shares available.
Read This: Milky Mist Dairy Food IPO GMP Today
Molbio Diagnostics IPO GMP Day-wise
Molbio Diagnostics IPO GMP is currently (12th Aug) ₹149 up, against the upper price band of ₹807, indicating 18.46% listing gain. Here are the GMP trends during the last 3 subscription days, based on various media reports and the Investor Gain website.
|
GMP Date |
IPO Price |
GMP (₹) |
Est. Listing Price |
Subscription |
|---|---|---|---|---|
|
12-Aug-2026 ( Day 3) |
₹807 |
₹149 |
₹956 (18.46%) |
70.27x |
|
11-Aug-2026 ( Day 2) |
₹807 |
₹138 |
₹945 (17.10%) |
2.95x |
|
10-Aug-2026 ( Day 1) |
₹807 |
₹127 |
₹934 (15.74%) |
0.83x |
Data source: Investor Gain
Although GMP is unofficial, highly volatile, and should not be treated as a guaranteed listing price.
GMP figures are for news purposes only. GMP data is sourced from various media houses. We neither trade in the grey market nor recommend trading based on GMP trends.
What’s Next After Molbio Diagnostics Allotment?
-
If shares are allotted, shares will reflect in your demat account on 14 Aug 2026.
-
If you don't receive an allotment, the blocked amount will be released on 14 Aug 2026.
-
Applicants receiving a partial allotment in Molbio Diagnostics will get the remaining amount unblocked.
-
After allotment, investors can track Molbio Diagnostics's listing-day demand and market sentiment for further cues.
Molbio Diagnostics IPO Listing Date and Time
Molbio Diagnostics shares will be listed on NSE and BSE on Monday, 17 Aug, at 10 am.
About Molbio Diagnostics
Molbio Diagnostics, incorporated in October 2000, is a molecular diagnostics company focused on rapid testing for infectious and non-communicable diseases. Its Truenat platform is a portable, battery-operated PCR system that can deliver test results within an hour.
The company offers 43 diagnostic tests covering more than 30 diseases, including TB, COVID-19, HIV, Hepatitis B & C and HPV. It also provides radiology, digital pathology and breast health screening solutions through its subsidiaries and partners.
Molbio operates six manufacturing facilities in India and serves customers in more than 90 countries, including hospitals, diagnostic labs and government health programmes.
Molbio Diagnostics IPO Financial Highlights
Molbio Diagnostics posted a PAT of ₹164 crore in FY26, compared with ₹83 crore in FY24. The company has also shown consistent improvement in PAT and PAT margin over the past three years. The key financial figures are presented in the table below
|
Period Ended |
31 Mar 2026 |
31 Mar 2025 |
31 Mar 2024 |
|---|---|---|---|
|
Revenue from Ops (₹ Cr) |
1445.69 |
1020.21 |
836.56 |
|
Total Income (₹ Cr) |
1,455.17 |
1,027.9 |
840.66 |
|
EBITDA (₹ Cr) |
328.24 |
256.64 |
185.09 |
|
EBITDA Margin (%) |
22.56 |
24.97 |
22.02 |
|
PAT (₹ Cr) |
164.14 |
138.58 |
83.54 |
|
PAT Margin (%) |
11.28 |
13.48 |
9.94 |
|
ROE (%) |
15.59 |
16.20 |
13.20 |
|
ROCE (%) |
17.55 |
20.98 |
15.80 |
Source: Molbio Diagnostics IPO RHP
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.